Cagent Vascular, Inc., the exclusive developer of serration technology for vessel dilation in endovascular interventions, today announced the start of the POINT FORCE Registry, a post-market clinical ...
Cagent Vascular, Inc., a developer of serration technology for vessel dilation in endovascular interventions, announced the sta ...
Following the recent IDE Approval by the U.S. Food and Drug Administration (FDA) for MagicTouch PTA, this enrolment heralds ...
PRNewswire Tampa Florida [US] January 21 Concept Medical Inc CMI a global leader in innovative drug-delivery technology ...
Concept Medical Inc. announced the completion of patient enrollment in the SirPAD trial of the company’s MagicTouch percu ...
The announcement followed the company receiving Investigational Device Exemption (IDE) from the US Food and Drug ...
Florida healthtech firm Concept Medical has enrolled the first patient in its MAGICAL trial examining its sirolimus-coated balloon against traditional angioplasty for patients living with below ...
A 0.18 wire‐compatible PTA balloon was then advanced into the cervical internal carotid artery (ICA) for balloon angioplasty using the stent retriever's wire, thus implementing a modified antegrade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback